- Home
- WTM vs ALKS Comparison
WTM vs ALKS Comparison
Compare WTM & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTM
- ALKS
- Stock Information
- Founded
- WTM 1980
- ALKS 1987
- Country
- WTM Bermuda
- ALKS Ireland
- Employees
- WTM N/A
- ALKS N/A
- Industry
- WTM Property-Casualty Insurers
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- WTM Finance
- ALKS Health Care
- Exchange
- WTM Nasdaq
- ALKS Nasdaq
- Market Cap
- WTM N/A
- ALKS 5.6B
- IPO Year
- WTM N/A
- ALKS 1991
- Fundamental
- Price
- WTM $1,844.43
- ALKS $33.31
- Analyst Decision
- WTM
- ALKS Buy
- Analyst Count
- WTM 0
- ALKS 12
- Target Price
- WTM N/A
- ALKS $38.36
- AVG Volume (30 Days)
- WTM 14.2K
- ALKS 1.9M
- Earning Date
- WTM 02-07-2025
- ALKS 04-30-2025
- Dividend Yield
- WTM 0.05%
- ALKS N/A
- EPS Growth
- WTM N/A
- ALKS 3.47
- EPS
- WTM 89.79
- ALKS 2.17
- Revenue
- WTM $2,354,300,000.00
- ALKS $1,557,632,000.00
- Revenue This Year
- WTM N/A
- ALKS N/A
- Revenue Next Year
- WTM N/A
- ALKS $4.37
- P/E Ratio
- WTM $20.78
- ALKS $15.43
- Revenue Growth
- WTM 8.66
- ALKS N/A
- 52 Week Low
- WTM $1,665.71
- ALKS $22.90
- 52 Week High
- WTM $2,023.00
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- WTM 45.43
- ALKS 47.10
- Support Level
- WTM $1,835.00
- ALKS $33.95
- Resistance Level
- WTM $1,931.35
- ALKS $35.58
- Average True Range (ATR)
- WTM 24.67
- ALKS 1.05
- MACD
- WTM 3.47
- ALKS -0.29
- Stochastic Oscillator
- WTM 31.77
- ALKS 3.64
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.